March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
DHA Restores HNE And PEDF By Inhibiting Oxidative Damage In RPE At High Glucose Levels
Author Affiliations & Notes
  • Emma Arnal
    FOM, Valencia, Spain
  • Siv Johnsen-Soriano
    FOM, Valencia, Spain
  • María Miranda
    Dpto. Ciencias Biomédicas, UCH-CEU, Moncada, Spain
  • Amparo Navea
    FOM, Valencia, Spain
  • Javier Romero
    FOM, Valencia, Spain
    Facultad de Medicina, UCV, Valencia, Spain
  • Footnotes
    Commercial Relationships  Emma Arnal, None; Siv Johnsen-Soriano, None; María Miranda, None; Amparo Navea, None; Javier Romero, None
  • Footnotes
    Support  GE-002/11 conselleria de Sanitat; Generalitat Valenciana
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6426. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Emma Arnal, Siv Johnsen-Soriano, María Miranda, Amparo Navea, Javier Romero; DHA Restores HNE And PEDF By Inhibiting Oxidative Damage In RPE At High Glucose Levels. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6426.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Diabetic retinopathy is a leading cause of visual loss and have been related to oxidative stress. The aim of the present study was to evaluate protective properties of Docosahexaenoic acid (DHA) at retinal pigment epithelial (RPE) cells exposed to high glucose levels.

Methods: : Human RPE cells (ARPE-19) were cultured 4 days with normal blood glucose concentration, followed by ten days exposure to either normal or high D-glucose concentration. DHA was administered according to the following groups: control group (C), control+DHA group (CDHA), glucose group (G) and glucose+DHA group (GDHA). At the end of the experiment cells were washed, sonicated and lysed and the homogenates cryopreserved until assayed.

Results: : Antioxidant Capacity, (AC), (0.97 ± 0.1μM/mg prot) and glutathione concentration (GSH) (0.25 ± 0.05 μmol/mg prot) in G group decreased significantly when compared to C group (1,52 ± 0.09 μM/mg prot and 0.61 ± 0.16 μmol/mg prot respectively); DHA administration normalized these alterations (1.41 ± 0.16 μM/mg prot (AC) and 0.51 ± 0.07 μmol/mg prot (GSH)). Moreover, the total nitrites (TN) and malondialdehyde (MDA) concentrations were significantly elevated in G group (1.09 ± 0.35 μmol/mg prot and 0.59 ± 0.16 μmol of MDA/mg prot respectively) when compared to the C group (0.53 ± 0.08 μmol/mg prot and 0.25 ± 0.05 μmol of MDA/mg prot), and DHA administration again normalized these alterations to normal values (0.49 ± 0.12 μmol/mg prot and 0.30 ± 0.03 μmol of MDA/mg prot; p<0,05). In addition, hydroxynonenal (HNE) and Pigment Epithelial Derived Factor (PEDF) immunohistochemical studies were performed. DHA restores HNE-positive cell density in GDHA group (42.59 ± 7.53 HNE-positive cells/total cells) when compared with G group (76.77 ± 12.7; p<0,05 ). Moreover, PEDF-positive cell number in GDHA group increased significantly (48.54 ± 12.53 PEDF-positive cells/total cells) when compared to G group (28.71 ± 7.73 PEDF-positive cells/total cells; p< 0,05).

Conclusions: : These data further support previous findings that suggest that DHA might be useful in protecting diabetic retina.

Keywords: antioxidants • retinal pigment epithelium • diabetic retinopathy 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.